Home/Filings/4/0001209191-17-002680
4//SEC Filing

CONCERT PHARMACEUTICALS, INC. 4

Accession 0001209191-17-002680

CIK 0001367920operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:03 PM ET

Size

5.4 KB

Accession

0001209191-17-002680

Insider Transaction Report

Form 4
Period: 2017-01-04
Daws D. Ryan
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-01-04+82,50082,500 total
    Exercise: $10.97Exp: 2027-01-03Common Stock (82,500 underlying)
Footnotes (1)
  • [F1]This option vests in sixteen equal quarterly installments beginning on April 4, 2017.

Issuer

CONCERT PHARMACEUTICALS, INC.

CIK 0001367920

Entity typeoperating

Related Parties

1
  • filerCIK 0001367920

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:03 PM ET
Size
5.4 KB